BORGATTI, Monica
 Distribuzione geografica
Continente #
NA - Nord America 24.801
AS - Asia 14.942
EU - Europa 12.182
SA - Sud America 2.452
AF - Africa 336
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 54.769
Nazione #
US - Stati Uniti d'America 24.288
SG - Singapore 5.501
FI - Finlandia 4.212
CN - Cina 4.045
BR - Brasile 1.957
IT - Italia 1.656
VN - Vietnam 1.545
DE - Germania 1.320
UA - Ucraina 1.197
HK - Hong Kong 1.190
PL - Polonia 1.181
TR - Turchia 815
GB - Regno Unito 750
FR - Francia 486
SE - Svezia 476
RU - Federazione Russa 372
JP - Giappone 362
IN - India 324
ID - Indonesia 235
CA - Canada 233
MX - Messico 199
AR - Argentina 173
BD - Bangladesh 169
NL - Olanda 130
ZA - Sudafrica 119
IQ - Iraq 103
PK - Pakistan 96
EC - Ecuador 87
ES - Italia 82
CO - Colombia 66
PH - Filippine 61
BE - Belgio 58
IR - Iran 57
MY - Malesia 54
UZ - Uzbekistan 54
VE - Venezuela 54
MA - Marocco 47
SA - Arabia Saudita 46
LT - Lituania 43
CL - Cile 42
AT - Austria 39
AE - Emirati Arabi Uniti 38
TN - Tunisia 33
AU - Australia 32
PY - Paraguay 32
KE - Kenya 30
EG - Egitto 28
KR - Corea 28
CZ - Repubblica Ceca 27
GR - Grecia 23
TH - Thailandia 22
JO - Giordania 21
CH - Svizzera 19
IL - Israele 17
ET - Etiopia 16
IE - Irlanda 16
NP - Nepal 16
OM - Oman 15
PE - Perù 15
AZ - Azerbaigian 14
DZ - Algeria 14
LB - Libano 14
RO - Romania 14
TW - Taiwan 14
JM - Giamaica 13
KZ - Kazakistan 13
CR - Costa Rica 12
PA - Panama 12
UY - Uruguay 12
BO - Bolivia 11
DO - Repubblica Dominicana 10
NZ - Nuova Zelanda 10
PT - Portogallo 10
BG - Bulgaria 9
BH - Bahrain 9
KG - Kirghizistan 9
LY - Libia 8
NG - Nigeria 8
PS - Palestinian Territory 8
RS - Serbia 8
TT - Trinidad e Tobago 8
AL - Albania 7
KW - Kuwait 7
LV - Lettonia 7
SI - Slovenia 7
AO - Angola 6
GE - Georgia 6
MN - Mongolia 6
SY - Repubblica araba siriana 6
EU - Europa 5
HU - Ungheria 5
MD - Moldavia 5
SV - El Salvador 5
CY - Cipro 4
EE - Estonia 4
GT - Guatemala 4
HN - Honduras 4
KH - Cambogia 4
NI - Nicaragua 4
SN - Senegal 4
Totale 54.692
Città #
Helsinki 3.850
Singapore 3.430
Ashburn 2.866
Woodbridge 2.258
Fairfield 1.902
Beijing 1.439
Chandler 1.407
Jacksonville 1.362
San Jose 1.362
Ann Arbor 1.296
Houston 1.219
Hong Kong 1.166
Warsaw 1.163
Santa Clara 1.067
Wilmington 802
Seattle 776
Cambridge 628
Ferrara 510
Ho Chi Minh City 506
Izmir 477
Nanjing 425
Dallas 374
Los Angeles 369
Hanoi 360
New York 343
Tokyo 340
Princeton 326
Lauterbourg 273
Munich 255
Boardman 232
Council Bluffs 184
Shanghai 176
Jakarta 162
San Diego 156
São Paulo 155
Bremen 154
Milan 152
Addison 150
Bologna 131
Nanchang 123
Shenyang 120
Mexico City 119
London 97
Orem 97
Tianjin 93
Turku 93
Changsha 85
Hebei 84
Redwood City 82
Porto Alegre 79
Chennai 78
Brooklyn 75
Da Nang 75
Hefei 74
Falls Church 73
Rio de Janeiro 73
Montreal 70
Jiaxing 68
Frankfurt am Main 67
Moscow 66
Johannesburg 64
Haiphong 63
Stockholm 63
Denver 61
Guangzhou 61
Toronto 61
Dearborn 59
The Dalles 59
Brussels 55
Buffalo 55
Chicago 54
Mountain View 54
Jinan 51
San Francisco 50
Tashkent 49
Falkenstein 48
Atlanta 47
Baghdad 47
Poplar 46
Auburn Hills 45
Phoenix 44
Rome 43
Hangzhou 42
Manchester 41
Boston 39
Belo Horizonte 37
Norwalk 37
Des Moines 36
Guayaquil 36
Mumbai 36
Verona 36
Zhengzhou 36
Curitiba 35
Dong Ket 35
Ningbo 34
Nuremberg 34
Ferrara di Monte Baldo 33
San Mateo 33
Amsterdam 32
Brasília 32
Totale 37.817
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.012
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.973
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 413
A validated cellular biobank for β-thalassemia 411
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 375
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 370
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 361
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 343
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 298
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 295
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 294
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 289
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 271
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 267
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 252
SPR-based non-invasive prenatal testing for fetal sex determination 250
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 247
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 242
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 241
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 239
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 233
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 232
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 232
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 232
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 230
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 228
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 225
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 225
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 224
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 224
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 223
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 221
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 221
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 219
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 219
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 218
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 218
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 217
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 217
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 216
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 215
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 214
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 213
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 212
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 212
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 211
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 210
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 209
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 208
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 207
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 206
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 206
Regulation of IL-8 gene expression in gliomas by microRNAs 202
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 202
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 202
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 200
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 199
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 199
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 199
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 198
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 197
Liposomes as carriers for DNA-PNA hybrids 193
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 193
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 191
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 191
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 191
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 189
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 187
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 187
Plants with antitumor properties:from biologically active molecules to drugs 186
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 185
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 185
Alteration of microRNA biological activity with peptide nucleic acid 184
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 183
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 183
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 182
Cellular biosensors for the identification of fetal hemoglobin inducers 182
Cellulose acetate microparticles for Lab-on-a-chip applications 182
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 182
Development of microRNA based protocols for detection of autologous blood transfusion in sport 182
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 182
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 179
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 179
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 179
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 178
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites 178
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 176
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 176
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 174
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 173
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 172
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 171
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 171
Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site 171
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 170
Development and molecular characterization of transgenic mice for beta-thalassemia 170
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 169
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 168
Totale 25.402
Categoria #
all - tutte 220.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.497
Totale 227.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.619 0 0 0 0 0 0 0 0 0 535 670 414
2021/20223.168 270 279 157 105 212 161 156 139 126 279 349 935
2022/20233.300 353 266 81 444 569 447 150 298 367 33 160 132
2023/20241.875 142 262 79 49 211 366 119 87 31 30 76 423
2024/20257.091 182 189 580 355 789 556 239 381 1.199 816 955 850
2025/202621.782 1.905 791 1.605 2.377 2.748 1.285 2.384 1.167 5.634 1.886 0 0
Totale 55.459